retatrutide clinical trials status 2025 Retatrutide, the next generation of GLP-1 drug from Eli Lilly, helped participants lose an average of 71.2 pounds and reduce knee arthritis pain in a late-stage trial, the company announced. In Retatrutide clinical trial done! Now
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16



























![Combusken (25/106) (Stamped) [EX: Emerald] 159](https://cdn.shopify.com/s/files/1/0580/9766/4113/files/64c9586d-79af-5c9e-85c6-a33df0ef6926.jpg?v=1732403636)